Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cheryl Baxter

Showing results (61-70 of 107) with videos related to

Pageof 11
Sort By:
Plos One|April 26, 2023
Evaluation of miniaturized Illumina DNA preparation protocols for SARS-CoV-2 whole genome sequencingSureshnee Pillay, James Emmanuel San, Derek Tshiabuila, et al.
The New England Journal of Medicine|August 6, 2015
Tenofovir Gel for the Prevention of Herpes Simplex Virus Type 2 InfectionSalim S Abdool Karim, Quarraisha Abdool Karim, Ayesha B M Kharsany, et al.
Journal of Immunological Methods|March 6, 2024
Performance of Softcup® menstrual cup and vulvovaginal swab samples for detection and quantification of genital cytokinesNashlin Pillay, Gugulethu Favourate Mzobe, Marothi Letsoalo, et al.
Nature Microbiology|December 22, 2022
SARS-CoV-2 Africa dashboard for real-time COVID-19 informationJoicymara S Xavier, Monika Moir, Houriiyah Tegally, et al.
BMJ Open|July 6, 2019
Assessing the safety and pharmacokinetics of the monoclonal antibodies, VRC07-523LS and PGT121 in HIV negative women in South Africa: study protocol for the CAPRISA 012A randomised controlled phase I trialSharana Mahomed, Nigel Garrett, Edmund Capparelli, et al.
Frontiers in Immunology|June 28, 2021
Recent Semen Exposure Impacts the Cytokine Response and Bacterial Vaginosis in WomenKhanyisile Mngomezulu, Gugulethu F Mzobe, Andile Mtshali, et al.
Frontiers in Immunology|August 1, 2020
Topical Tenofovir Pre-exposure Prophylaxis and Mucosal HIV-Specific Fc-Mediated Antibody Activities in WomenKimone Leigh Fisher, Jennifer M Mabuka, Aida Sivro, et al.
Scientific Reports|December 7, 2021
Higher mucosal antibody concentrations in women with genital tract inflammationParveen Sobia, Thevani Pillay, Lenine J P Liebenberg, et al.
Antiviral Therapy|August 24, 2012
Safety of tenofovir gel, a vaginal microbicide, in South African women: results of the CAPRISA 004 TrialDavid C Sokal, Quarraisha Abdool Karim, Sengeziwe Sibeko, et al.
The Journal of Infectious Diseases|April 21, 2012
Symptomatic vaginal discharge is a poor predictor of sexually transmitted infections and genital tract inflammation in high-risk women in South AfricaKoleka Mlisana, Nivashnee Naicker, Lise Werner, et al.
Pageof 11

Showing results (61-70 of 107) with videos related to

Sort By:
Pageof 11
Plos One|April 26, 2023
Evaluation of miniaturized Illumina DNA preparation protocols for SARS-CoV-2 whole genome sequencingSureshnee Pillay, James Emmanuel San, Derek Tshiabuila, et al.
The New England Journal of Medicine|August 6, 2015
Tenofovir Gel for the Prevention of Herpes Simplex Virus Type 2 InfectionSalim S Abdool Karim, Quarraisha Abdool Karim, Ayesha B M Kharsany, et al.
Journal of Immunological Methods|March 6, 2024
Performance of Softcup® menstrual cup and vulvovaginal swab samples for detection and quantification of genital cytokinesNashlin Pillay, Gugulethu Favourate Mzobe, Marothi Letsoalo, et al.
Nature Microbiology|December 22, 2022
SARS-CoV-2 Africa dashboard for real-time COVID-19 informationJoicymara S Xavier, Monika Moir, Houriiyah Tegally, et al.
BMJ Open|July 6, 2019
Assessing the safety and pharmacokinetics of the monoclonal antibodies, VRC07-523LS and PGT121 in HIV negative women in South Africa: study protocol for the CAPRISA 012A randomised controlled phase I trialSharana Mahomed, Nigel Garrett, Edmund Capparelli, et al.
Frontiers in Immunology|June 28, 2021
Recent Semen Exposure Impacts the Cytokine Response and Bacterial Vaginosis in WomenKhanyisile Mngomezulu, Gugulethu F Mzobe, Andile Mtshali, et al.
Frontiers in Immunology|August 1, 2020
Topical Tenofovir Pre-exposure Prophylaxis and Mucosal HIV-Specific Fc-Mediated Antibody Activities in WomenKimone Leigh Fisher, Jennifer M Mabuka, Aida Sivro, et al.
Scientific Reports|December 7, 2021
Higher mucosal antibody concentrations in women with genital tract inflammationParveen Sobia, Thevani Pillay, Lenine J P Liebenberg, et al.
Antiviral Therapy|August 24, 2012
Safety of tenofovir gel, a vaginal microbicide, in South African women: results of the CAPRISA 004 TrialDavid C Sokal, Quarraisha Abdool Karim, Sengeziwe Sibeko, et al.
The Journal of Infectious Diseases|April 21, 2012
Symptomatic vaginal discharge is a poor predictor of sexually transmitted infections and genital tract inflammation in high-risk women in South AfricaKoleka Mlisana, Nivashnee Naicker, Lise Werner, et al.
Pageof 11